Perforated peptic ulcer in southeastern Taiwan

Background:  No studies focus on the population with perforated peptic ulcer in southeastern Taiwan. The present study aimed to assess the differences between the different races and the risk factors related to mortality and morbidity in postoperative patients in southeastern Taiwan.

[1]  B. Kocer,et al.  Factors affecting mortality and morbidity in patients with peptic ulcer perforation , 2007, Journal of gastroenterology and hepatology.

[2]  H. Kulkarni,et al.  A prospective cohort study of postoperative complications in the management of perforated peptic ulcer , 2006, BMC surgery.

[3]  J. Gisbert,et al.  Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[4]  P. Portincasa,et al.  Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. , 2003, World journal of gastroenterology.

[5]  E. Matos,et al.  Perforated Peptic Ulcer: Main Factors of Morbidity and Mortality , 2003, World Journal of Surgery.

[6]  P. Ohtonen,et al.  Factors that predict morbidity and mortality in patients with perforated peptic ulcers. , 2002, The European journal of surgery = Acta chirurgica.

[7]  C. Kum,et al.  Risk factors related to operative mortality and morbidity in patients undergoing emergency gastrectomy , 2000, The British journal of surgery.

[8]  T. Sillakivi,et al.  Evaluation of risk factors for mortality in surgically treated perforated peptic ulcer. , 2000, Hepato-gastroenterology.

[9]  C. Ohmann,et al.  Perforated peptic ulcer: is there a difference between Eastern Europe and Germany? , 2000, Langenbeck's Archives of Surgery.

[10]  S. Hernández-Díaz,et al.  Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.

[11]  K. Soo,et al.  Adverse operative risk factors for perforated peptic ulcer. , 2000, Annals of the Academy of Medicine, Singapore.

[12]  P. Chwirot,et al.  Perforated peptic ulcer--time trends and patterns over 20 years. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[13]  C. Svanes.  Trends in Perforated Peptic Ulcer: Incidence, Etiology, Treatment, and Prognosis , 2000, World Journal of Surgery.

[14]  C. Tsai,et al.  Risk factors of mortality in perforated peptic ulcer. , 2000, The European journal of surgery = Acta chirurgica.

[15]  T. Zilling,et al.  Surgical approach and prognostic factors after peptic ulcer perforation. , 1999, The European journal of surgery = Acta chirurgica.

[16]  S. Vollset,et al.  Smoking and ulcer perforation , 1997, Gut.

[17]  K. Byth,et al.  Some factors associated with mortality in perforated peptic ulcer: A case‐control study , 1996, Journal of gastroenterology and hepatology.

[18]  W. Pan,et al.  Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. , 1994, Anticancer research.

[19]  K. Svanes,et al.  Perforated peptic ulcer over 56 years. Time trends in patients and disease characteristics. , 1993, Gut.

[20]  K. Byth,et al.  Perforated peptic ulcer in Hong Kong and New South Wales , 1992, Journal of gastroenterology and hepatology.

[21]  L. Carey,et al.  Preoperative serum creatinine as a predictor of survival in perforated gastroduodenal ulcer. , 1985, The American surgeon.